In a landmark move that places the UK at the forefront of international health innovation, the country has become the first to join a new global network of regulators dedicated to ensuring the safe and effective use of artificial intelligence (AI) in healthcare.
The Medicines and Healthcare products Regulatory Agency (MHRA) has joined as a founding ‘Pioneer’ country in the HealthAI Global Regulatory Network, an initiative that aims to fast-track the delivery of trusted AI tools into clinical settings while maintaining rigorous safety and ethical standards.
A trusted partner internationally
The development is set to position the UK not only as a global leader in health tech regulation but as a trusted partner in the international effort to harness AI’s transformative potential. With the power to support earlier diagnosis, reduce NHS waiting times and foster growth in the domestic health technology sector, AI is increasingly seen as a cornerstone of the future of patient care.
As part of the network, the MHRA will work alongside international counterparts to share early safety alerts, monitor AI performance in real-world settings, and co-develop international standards. More countries are expected to join the initiative in the coming months, creating an unprecedented platform for global collaboration on AI regulation.
The AI Airlock
Drawing on its pioneering work at home, the MHRA will help shape the network from the ground up. One of its most notable contributions is the AI Airlock, an internationally recognised regulatory sandbox that allows developers to test AI medical devices in a controlled environment before they are deployed across the NHS. Projects already in the pipeline include AI models to help GPs detect lung conditions sooner and tools to personalise cancer care.
Backed by updated guidance and ongoing reforms to medical device regulation, the MHRA continues to adapt to rapidly advancing fields such as generative and adaptive AI. The agency is also collaborating with researchers, NICE (National Institute for Health and Care Excellence) and the NHS to strengthen the evidence base on how AI performs in practice, ensuring patient safety remains paramount.
Formal signing in Westminster
A formal signing ceremony took place in Westminster to mark the UK’s entry into the network, attended by Science Minister Lord Vallance, MHRA Chief Executive Lawrence Tallon, and Dr Ricardo Baptista Leite, CEO of HealthAI.
Health and Social Care Secretary Wes Streeting hailed the move as a sign of the UK’s leadership in responsible innovation. “Cutting-edge technology will be crucial to transforming patient care and NHS efficiency,” he said, stressing that global cooperation would help unlock AI’s full potential without compromising on ethics or safety.
Science and Technology Secretary Peter Kyle added that the UK is “breaking down unnecessary regulatory barriers” to help trusted AI tools reach patients faster, improving outcomes while also supporting wider economic growth.
As AI continues to reshape the healthcare landscape, the UK’s leadership in this emerging field is being firmly cemented.
